Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 113-121
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.113
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.113
Use of methotrexate in inflammatory bowel disease in 2014: A User’s Guide
Arun Swaminath, Raja Taunk, IBD Program, NorthShore Hospital System, Lenox Hill Hospital, New York, NY 10075, United States
Arun Swaminath, Division of Gastroenterology, Lenox Hill Hospital, New York, NY 10075, United States
Garrett Lawlor, NY Harbor Veteran’s Affairs Healthcare system, Brooklyn Campus, Brooklyn, NY 11201, United States
Author contributions: Swaminath A contributed to idea for paper, drafting manuscript, critical revision and editing of content; Taunk R and Lawlor G contributed to analysis and review of data, drafting of manuscript.
Correspondence to: Arun Swaminath, MD, Division of Gastroenterology, Lenox Hill Hospital, 100 East 77th Street, 2nd Floor, New York, NY 10075, United States. aswaminath@nshs.edu
Telephone: +1-212-4346963 Fax: +1-212-4346275
Received: March 4, 2014
Revised: April 10, 2014
Accepted: June 20, 2014
Published online: August 6, 2014
Revised: April 10, 2014
Accepted: June 20, 2014
Published online: August 6, 2014
Core Tip
Core tip: Methotrexate can a be a useful adjunct to the treatment of inflammatory bowel disease, but many practitioners are unfamiliar with it’s use. Here, we have provided a succinct summary of the data behind the use of methotrexate and a short “user’s guide” and algorithm to allow for the busy clinician to become quickly familiar with the drug and information to help prescribe it safely.